Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review
Cristina Aparicio, Carlos Acebal, Margarita González‐Vallinas
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 47
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 17
Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
Shaida Ouladan, Elias Orouji
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 3
Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Emile M. Youssef, Brandon Fletcher, Dannelle Palmer
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 3
Enhancing pediatric access to cell and gene therapies
Crystal L. Mackall, Catherine M. Bollard, Nancy L. Goodman, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1836-1846
Closed Access | Times Cited: 10
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Ugo Testa, Simona Sica, Elvira Pelosi, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024010-e2024010
Open Access | Times Cited: 9
Challenges and strategies associated with CAR-T cell therapy in blood malignancies
Zhaoyun Liu, Wenhui Lei, Hao Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 9
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment
Asif Nawaz, Nur Aisya Affrina Mohamed Ariffin, Wong Tin Wui
Asian Journal of Pharmaceutical Sciences (2025), pp. 101041-101041
Open Access | Times Cited: 1
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
“Off-The-Shelf” allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges
Razan Mohty, Aleksandr Lazaryan
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
Maryam Amiri, Amir Kian Moaveni, Masoumeh Majidi Zolbin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)
Lele Miao, Juan Zhang, Wei Xu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di, Christopher T. Su, Andrew J. Cowan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 10, pp. 1418-1429
Closed Access | Times Cited: 6
The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy
Jie Li, Mengjie Che, Bin Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189007-189007
Open Access | Times Cited: 11
DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells
Maria Cristina Grimaldi, Sara Bozzer, Dick J. Sjöström, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
CAR T-cell Therapy Landscape in Pediatric, Adolescent and Young Adult Oncology - A Comprehensive Analysis of Clinical Trials
David A Martínez-Gamboa, Rhea Hans, Eider Moreno-Cortes, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104648-104648
Closed Access
CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View
Sara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Chimeric Antigen Receptor T Cell Immunotherapy for Gynecological Malignancies
Yajuan Gao, Jing He, Jing Wang, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104680-104680
Closed Access
New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies
Karolina Rassek, Jan Misiak, Tomasz Ołdak, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cell therapies against brain tumors: Clinical development and emerging prospects
Tatsuya Fukuta, Suyog Shaha, Andrés da Silva‐Candal, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer
Zibai Lyu, Shaoqiang Niu, Ying Fang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Bridging the Gap Between Bone Marrow Transplantation and CAR-T Cell Therapy in Hematological Cancers
Babak Arjmand, Fatemeh Shahrahmani, Ahmadreza Mirzaei, et al.
Advances in experimental medicine and biology (2025)
Closed Access
Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions
Leonard Knoedler, J. H. Dean, Fortunay Diatta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top